Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000176

Chairperson & CEO sold 9,500 shares at an average $600.09 ($5,700,856)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

14 lines
Date Transaction Shares Price Value Owned after D/I
2026-10-30 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $117.76 $1,118,720 333,943 I
2026-10-30 Sale : show line 2 in the form 10b5-1 −119 $594.92 $70,795 333,824 I
2026-10-30 Sale : show line 3 in the form 10b5-1 −728 $596.01 $433,893 333,096 I
2026-10-30 Sale : show line 4 in the form 10b5-1 −393 $596.84 $234,557 332,703 I
2026-10-30 Sale : show line 5 in the form 10b5-1 −1,496 $598.04 $894,664 331,207 I
2026-10-30 Sale : show line 6 in the form 10b5-1 −884 $598.94 $529,465 330,323 I
2026-10-30 Sale : show line 7 in the form 10b5-1 −1,200 $600.25 $720,302 329,123 I
2026-10-30 Sale : show line 8 in the form 10b5-1 −1,742 $600.96 $1,046,865 327,381 I
Open-market sales · 9,500 sh · avg $600.09 · $5,700,856

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-10-30 Exercise or conversion : show line 15 in the form 10b5-1 Stock Option −9,500 119,410 I
Loading xslF345X06/primarydocument.xml…